Formulary Monographs [ACYCLOVIR, 081832]
|
|
ACYCLOVIR
|
|
|
|
|
|
NUCLEOSIDES AND NUCLEOTIDES
|
|
|
Effective in treating initial or recurrent herp es simplex virus, herp es
zoster and varicella zoster virus infections. |
|
|
Acyclovir is generally well tolerated. GI disturbances, renal failure, local reactions at the injection site, headache and rash may occur. A finger cot or rubber glove should be utilized for ap p lication to prevent auto-innoculation of other body sites.
|
|
|
Adult: For the treatment of initial genital herp es: 200mg orally 5 times daily for 7-10 days. For the treatment of herpes zoster: 800mg orally 5 times daily . For chronic suppressive therapy for recurrent diseases 400mg twice daily (or 200
|
|
|
|
|
|
With systemic use:
Not known to be harmful—manufacturers advise use only when potential benefit outweighs risk. |
|
|
With systemic use:
Significant amount in milk after systemic administration—not known to be harmful but manufacturer advises caution. |
|
|
|